Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 164, pseudogene (RN7SL164P) is a processed pseudogene derived from the functional 7SL RNA gene, which encodes the non-coding RNA component of the signal recognition particle (SRP)[1][3][5]. While functional 7SL RNA is essential for co-translational protein targeting to the endoplasmic reticulum and participates in critical cellular pathways, pseudogenes such as RN7SL164P are generally considered *non-functional remnants* produced via retrotransposition events[2][5]. Most RN7SL pseudogenes do not encode functional RNA or protein, though some pseudogenes in other gene families have been shown to influence the expression of their parental genes through microRNA (miRNA) decoy mechanisms[2]. There is currently no evidence that RN7SL164P itself has a therapeutic target role, interacts with drugs, or serves as a biomarker. There is also no direct association of RN7SL164P with disease biology. **Notes**: - RN7SL164P is not a protein-coding gene, receptor, enzyme, or transporter, nor is it recognized as a therapeutic target. - "Pseudogene" in this context denotes a genomic sequence with high similarity to a gene (here, 7SL RNA), but usually without a functional product[2][5]. - The entry is likely "incorrect" or at least not suitable for a "target" database, as it represents a non-functional genetic element and not a molecule suitable for therapeutic modulation or biomarker development. - Functional 7SL RNA (RN7SL1), not the pseudogene, is integral to essential SRP-mediated cellular processes[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 164, pseudogene (RN7SL164P).